107 related articles for article (PubMed ID: 9663604)
1. Cellular kinetic differences between Hodgkin's and anaplastic large cell lymphomas: relation to the expression of p34cdc2 and cyclin B-1.
Leoncini L; Megha T; Lazzi S; Bellan C; Luzi P; Tosi P; Cevenini G; Barbini P; Ascani S; Briskomatis A; Pileri S; Kraft R; Laissue JA; Cottier H
Int J Cancer; 1998 Jul; 77(3):408-14. PubMed ID: 9663604
[TBL] [Abstract][Full Text] [Related]
2. CD30 differential staining is useful in classifying lymphomas intermediate between Hodgkin's disease and anaplastic large cell (Ki1) lymphoma.
Schmidt U; Metz KA; Möser U
Tumori; 1998; 84(6):695-700. PubMed ID: 10080680
[TBL] [Abstract][Full Text] [Related]
3. Expression of p34(cdc2) and cyclins A and B compared to other proliferative features of non-Hodgkin's lymphomas: a multivariate cluster analysis.
Leoncini L; Cossu A; Megha T; Bellan C; Lazzi S; Luzi P; Tosi P; Barbini P; Cevenini G; Pileri S; Giordano A; Kraft R; Laissue JA; Cottier H
Int J Cancer; 1999 Oct; 83(2):203-9. PubMed ID: 10471528
[TBL] [Abstract][Full Text] [Related]
4. Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients.
Kagami Y; Suzuki R; Taji H; Yatabe Y; Takeuchi T; Maeda S; Kondo E; Kojima M; Motoori T; Mizoguchi Y; Okamoto M; Ohnishi K; Yamabe H; Seto M; Ogura M; Koshikawa T; Takahashi T; Kurita S; Morishima Y; Suchi T; Nakamura S
Am J Surg Pathol; 1999 Oct; 23(10):1184-200. PubMed ID: 10524519
[TBL] [Abstract][Full Text] [Related]
5. Expression of the G2-M checkpoint regulators cyclin B1 and P34CDC2 in breast cancer: a correlation with cellular kinetics.
Megha T; Lazzi S; Ferrari F; Vatti R; Howard CM; Cevenini G; Leoncini L; Luzi P; Giordano A; Tosi P
Anticancer Res; 1999; 19(1A):163-9. PubMed ID: 10226538
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules.
Foss HD; Anagnostopoulos I; Araujo I; Assaf C; Demel G; Kummer JA; Hummel M; Stein H
Blood; 1996 Nov; 88(10):4005-11. PubMed ID: 8916967
[TBL] [Abstract][Full Text] [Related]
7. Abortive mitoses and nuclear DNA fragmentation in CD30+ large cells of Hodgkin's disease.
Leoncini L; Spina D; Close P; Megha T; Pacenti L; Tosi P; Pileri S; De Vivo A; Kraft R; Laissue JA; Cottier H
Leuk Lymphoma; 1996 Jun; 22(1-2):119-24, follow. 186, color plate XI. PubMed ID: 8724538
[TBL] [Abstract][Full Text] [Related]
8. Large cell anaplastic Ki-1+ non-Hodgkin's lymphoma vs. Hodgkin's disease in fine needle aspiration biopsy samples.
Bizjak-Schwarzbartl M
Acta Cytol; 1997; 41(2):351-6. PubMed ID: 9100766
[TBL] [Abstract][Full Text] [Related]
9. CD30 activates both the canonical and alternative NF-kappaB pathways in anaplastic large cell lymphoma cells.
Wright CW; Rumble JM; Duckett CS
J Biol Chem; 2007 Apr; 282(14):10252-62. PubMed ID: 17261581
[TBL] [Abstract][Full Text] [Related]
10. mRNA expression patterns indicate CD30 mediated activation of different apoptosis pathways in anaplastic large cell lymphoma but not in Hodgkin's lymphoma.
Staber PB; Noehammer C; Dürkop H; Schauer S; Kenner L; Linkesch W; Hoefler G
Leuk Res; 2006 Mar; 30(3):343-8. PubMed ID: 16198418
[TBL] [Abstract][Full Text] [Related]
11. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study.
Leoncini L; Del Vecchio MT; Kraft R; Megha T; Barbini P; Cevenini G; Poggi S; Pileri S; Tosi P; Cottier H
Am J Pathol; 1990 Nov; 137(5):1047-57. PubMed ID: 2173409
[TBL] [Abstract][Full Text] [Related]
12. Expression of the c-kit receptor in human lymphomas is restricted to Hodgkin's disease and CD30+ anaplastic large cell lymphomas.
Pinto A; Gloghini A; Gattei V; Aldinucci D; Zagonel V; Carbone A
Blood; 1994 Feb; 83(3):785-92. PubMed ID: 7507733
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic molecule expression is predictive of prognosis in Hodgkin's-like anaplastic large cell lymphoma.
Asano N; Suzuki R; Matsuo K; Kagami Y; Ishida F; Tamaru JI; Jin GS; Sato Y; Shimoyama Y; Yoshino T; Morishima Y; Nakamura S
Histopathology; 2007 May; 50(6):705-15. PubMed ID: 17493234
[TBL] [Abstract][Full Text] [Related]
14. CD30 antigen in non-Hodgkin's lymphoma.
Miyake K; Yoshino T; Sarker AB; Teramoto N; Akagi T
Pathol Int; 1994 Jun; 44(6):428-34. PubMed ID: 8055109
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of thymus and activation regulated chemokine and its receptor CCR4 in nodal and cutaneous anaplastic large-cell lymphomas and Hodgkin's disease.
Vermeer MH; Dukers DF; ten Berge RL; Bloemena E; Wu L; Vos W; de Vries E; Tensen CP; Meijer CJ; Willemze R
Mod Pathol; 2002 Aug; 15(8):838-44. PubMed ID: 12181269
[TBL] [Abstract][Full Text] [Related]
16. Effects of adenovirus-mediated expression of p27Kip1, p21Waf1 and p16INK4A in cell lines derived from t(2;5) anaplastic large cell lymphoma and Hodgkin's disease.
Turturro F; Arnold MD; Frist AY; Seth P
Leuk Lymphoma; 2002 Jun; 43(6):1323-8. PubMed ID: 12153002
[TBL] [Abstract][Full Text] [Related]
17. [Dipeptidyl aminopeptidase-IV as a histochemical marker of differential diagnosis of large cell anaplastic CD30+-lymphoma and Hodgkin's disease].
Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Pavlovskaia AI; Tupitsyn NN; Sholokhova EN
Arkh Patol; 2000; 62(4):3-8. PubMed ID: 10971865
[TBL] [Abstract][Full Text] [Related]
18. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of CD30 activation in anaplastic large cell lymphoma and Hodgkin disease cells.
Mir SS; Richter BW; Duckett CS
Blood; 2000 Dec; 96(13):4307-12. PubMed ID: 11110706
[TBL] [Abstract][Full Text] [Related]
20. CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells.
Hirsch B; Hummel M; Bentink S; Fouladi F; Spang R; Zollinger R; Stein H; Dürkop H
Am J Pathol; 2008 Feb; 172(2):510-20. PubMed ID: 18187570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
